학술논문
WCN24-773 SPARSENTAN AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY: PRELIMINARY FINDINGS FROM THE SPARTAN TRIAL
Document Type
Abstract
Author
Source
In Kidney International Reports April 2024 9(4) Supplement:S142-S142
Subject
Language
ISSN
2468-0249